Original Research
Published on 30 Apr 2025
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 1,407 views